SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Dogecoin is a cryptocurrency based on the popular "Doge" Internet meme and features a Shiba Inu on its logo. Dogecoin is a Litecoin fork. Introduced as a "joke currency" on 6 December 2013, Dogecoin quickly developed its own online community and reached a capitalization of US$60 million in January 2014. Compared with other cryptocurrencies, Dogecoin had a fast initial coin production schedule: 100 billion coins were in circulation by mid-2015, with an additional 5.256 billion coins every year thereafter. As of 30 June 2015, the 100 billionth Dogecoin had been mined.   Dogecoin was created by Billy Markus from Portland, Oregon and  Jackson Palmer from Sydney, Australia. Both wanted to create a fun cryptocurrency that will appeal beyond the core Bitcoin audience. Dogecoin is primarily used as a tipping system on Reddit and Twitter where users tip each other for creating or sharing good content. The community is very active in organising fundraising activities for deserving causes.  The developers of Dogecoin haven’t made any major changes to the coin since 2015. This means that Dogecoin could get left behind and is why Shibas are leaving Dogecoin to join more advanced platforms like Ethereum. One of Dogecoin strengths is its relaxed and fun-loving community. However, this is also a weakness because other currencies are way more professional.  To purchase Dogecoin, it involves downloading a crypto wallet, setting up a crypto exchange account and then trading away for your desired crypto currency. Once we have set up an account with a DOGE currency exchange and deposited some funds, you are ready to start trading.

Dogecoin

Dogecoin is trending as the community discusses a recent spike and potential catalysts. Bullish sentiment is fueled by speculation around a possible ETF, with some anticipating a significant price increase. Others are cautioning against getting caught up in hype and promoting alternative coins.

Uniting the six native Japanese dog breeds. Kendu is the keeper of peace, the preserver of life, and the protector of unity. Join the pack!!

Kendu

$KENDU.X is gaining attention as community members highlight its strong, active community and real-world applications. Discussions revolve around the increasing holder count, dedicated community initiatives, and the potential for significant growth. The community emphasizes its organic growth and real-world brand building.

Dog (Bitcoin) is a fully decentralized memecoin on the Bitcoin blockchain, backed by a community dedicated to onboarding millions of people to Bitcoin.  Dog is secured by the Bitcoin blockchain and exists on Bitcoin L1, marking a significant innovation compared to Bitcoin with just BTC. Dog is a Bitcoin Runes token with a minimal on-chain footprint, native to Bitcoin, and stored in UTXOs, just like Bitcoin.   What is the project about?  Dog does not do any paid promotion and is fully decentralized just like Bitcoin. Every influencer who chooses to post about Dog either received the airdrop or bought on secondary. Dog leverages the CC0 license to ensure that Dog is not owned by any single entity but rather by everyone. This had lead to the "DOG Army" independently creating art, apps, lotteries, plushies, websites, podcast, magazines, X account, IRL meetups, clothing lines, PFP collections, Telegram groups, and TikTok/Instagram about Dog.  What makes your project unique?  Dog was airdropped in the fairest memecoin launch ever. In early 2024, the Bitcoin Ordinals ecosystem came together in a full volunteer initiative that rewarded early adopters of the Ordinals Protocol. There was no team allocation, and 100% of the supply was airdropped for free. The airdrop algorithm favored neither whales nor influencers; it was determined by the community and made open-source for maximum transparency.

Dog (Bitcoin)

$DOG.X is trending as the community rallies around its position as the first meme coin on Bitcoin, emphasizing its fair launch and strong community-driven growth. Discussion highlights its unique utility in strengthening the Bitcoin network through miner fees, setting it apart from other meme coins. Some believe $DOG.X has the potential to outperform other meme coins like $DOGE.X.

Summit Therapeutics, Inc. is a biopharmaceutical company, that focuses on the discovery, development, and commercialization of patient, physician, caregiver, and societal-friendly medicinal therapies intended to improve quality of life, increase potential duration of life, and resolve serious unmet medical needs. The firm conducts clinical programs focusing on Clostridioides Difficile Infection (CDI). Its lead product, Ridinilazole, is an orally administered small molecule antibiotic that is in Phase III clinical trials for the treatment of CDI. The company was founded in 2003 and is headquartered in Miami, FL.

Summit Therapeutics Inc

Summit Therapeutics is trending due to positive updated Phase 3 HARMONi data for its lung cancer drug, ivonescimab, sparking optimism about its potential. The community is focused on the drug's OS benefit and its competitive efficacy compared to existing treatments, while also debating the validity and interpretation of trial data. Some investors are speculating about a potential acquisition or partnership, particularly with AstraZeneca, driving further interest in the stock.

ProShares Trust - ProShares Short Dow30 -1x Shares

ProShares Short Dow30

The crypto community is focused on the $DOG memecoin on the Bitcoin network, highlighting its fair launch and strong community. Many believe $DOG has the potential to become the leading memecoin on Bitcoin, even suggesting it could surpass $DOGE. Discussions also involve its listing on major exchanges like Kraken and its role within the Bitcoin Runes ecosystem.

Concordium is a public, permissionless Layer 1 blockchain designed for businesses that require regulatory compliance without sacrificing privacy. Concordium was among the first to mandate identity verification at the blockchain consensus level while integrating zero-knowledge proofs (ZKPs) for selective disclosure. Launched in 2018, it embeds encrypted identity into every transaction at the protocol level, enabling accountability while preserving user confidentiality.  The project is backed by industry leaders from Volvo, IKEA, and Credit Suisse, among others, and aims to make blockchain adoption seamless for enterprises. Concordium has secured €52M in funding and partnered with Geely, a global automaker and co-owner of Volvo Cars, Volvo AB, and Daimler.  The newly appointed CEO and Executive Management team have revealed a focused strategic direction to double down on enabling stablecoin issuers, financial institutions, and payment providers to accelerate real-world adoption. With stablecoin settlement volumes projected to reach $300 billion per day by 2025, Concordium delivers a blockchain infrastructure uniquely suited for secure, programmable money solutions.

Concordium

Concordium is trending as the community discusses its potential as a turnaround play, highlighting its focus on PayFi and stablecoins. Some users point to a gradual upward movement as a positive sign, while others speculate about future price levels. The discussion also involves the team's background and potential partnerships.

Seres Therapeutics, Inc. engages in the development of biological drugs through microbiome therapeutics platform. Its product pipeline includes SER-109, SER-287, SER-301, and SER-401. The company was founded by Geoffrey von Maltzahn, David A. Berry, and Noubar B. Afeyan on October 18, 2010 and is headquartered in Cambridge, MA.

Seres Therapeutics Inc

Seres Therapeutics is trending amid community speculation of a potential buyout offer from Nestlé, fueled by reports of a substantial per-share offer that could trigger a major short squeeze given the stock's high short interest. The community is weighing the credibility of the reports, while also considering the implications of recent leadership changes and an upcoming conference presentation. Some investors believe a deal is imminent, while others are waiting for official confirmation and evaluating the potential for milestone payments.

Opendoor Technologies, Inc. engages in the operation of buying, selling, and trading of residential properties online. The company was founded by Eric Wu on December 30, 2013, and is headquartered in Tempe, AZ.

Opendoor Technologies Inc

Opendoor is trending as the community anticipates a new CEO announcement and discusses the potential impact of celebrity endorsements. Bullish sentiment is fueled by speculation of a short squeeze and potential rate cuts, while some traders express concern about the company's fundamentals and analyst ratings. The "OPEN Army" is actively encouraging each other to hold strong against perceived short sellers.

BrokeCoin is a meme-meets-utility cryptocurrency project operating under the ethos of Transparency, Community, and Respect. Formally registered as an LLC in Wyoming, USA, BrokeCoin is building an expansive ecosystem that combines light-hearted spirit of meme culture with real-world crypto utilities—spanning gaming, staking, NFTs, web services, and an e-commerce platform. Brokecoin believes in developing useful and interesting meme-inspired utilities to both service the crypto industry, and generate value for holders.

Brokecoin

$BROKE.X is trending due to its active community and ongoing development, including a soon-to-be-released staking app and upcoming token burns. Community members are actively discussing its strong performance relative to other cryptos and anticipating the new staking utility. The project's dedicated developer and engaged community are key talking points.

Our mission is to democratize real estate investment by providing accessible education and innovative tools. Through our learn-to-earn platform and tokenization hub, we're bridging the gap between traditional real estate and the future of decentralized finance. GCoin is the fuel to our ecosystem that powers our platform and gives us the ability and the community to spread this information that has been locked away by the wealthy.

GCoin

GCoin ($GC.X) is trending as the community highlights its real estate-backed utility and passive income opportunities through NFT holdings, with weekly payouts fueling excitement. Discussions emphasize $GC.X's role in tokenizing real-world assets and its connection to the Gilmore Estates ecosystem, built on the Hedera network. The recent launch on Uniswap and new partnerships also contribute to the growing buzz around $GC.X.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Active ETFs Catch a Wave of Investor Interest 

Should JPMorgan BetaBuilders U.S. Small Cap Equity ETF (BBSC) Be on Your Investing Radar?

Should Vanguard Small-Cap Value ETF (VBR) Be on Your Investing Radar?

Should iShares Russell 2000 Value ETF (IWN) Be on Your Investing Radar?

Is Schwab Fundamental U.S. Small Company ETF (FNDA) a Strong ETF Right Now?

Is Invesco S&P SmallCap 600 Pure Value ETF (RZV) a Strong ETF Right Now?

Should Invesco S&P SmallCap 600 Pure Value ETF (RZV) Be on Your Investing Radar?

Lovesac Co (LOVE) shares rose 16% on Thursday and saw a reversal of retail sentiment to bullish, after the furniture retailer reported fourth-quarter results that beat expectations.Revenue decreased 3.6% to $241.5 million but beat analyst expectations of $230.3 million. Earnings of $2.13 per share also exceeded the expectations of $1.87 per share.“After a slow start to the holiday selling season, strong execution by our teams dramatically improved conversion of customer quotes to sales throughout the remainder of the fourth quarter," said CEO Shawn Nelson in a statement."While macro conditions were, and remain, frustratingly challenging, we are optimistic and enter Fiscal 2026 in a position of strength."Lovesac is known for its giant beanbags called "Sacs", which are filled with a proprietary Durafoam blend instead of beans or beads. They are available in multiple sizes and with interchangeable covers.For its fiscal first quarter, the company expects revenue in the range of $136 million to $142 million and earnings in the range $0.66 to $0.85.Lovesac said the guidance considers the potential impact of the new U.S. import tariffs; however, "given the fluidity of the recent developments," it cannot predict the impact with certainty.The company relies on manufacturers in Vietnam, Malaysia, and Indonesia for some of its products.On Stocktwits, retail sentiment reversed to 'extremely bullish' from 'extremely bearish' within a day, and message volume remained 'extremely high.'<figure class="image"><img style="aspect-ratio:811/186;" src="https://news.stocktwits-cdn.com/Screenshot_2025_04_11_at_1_34_44_PM_png_22b381e2dd.webp" alt="Screenshot 2025-04-11 at 1.34.44 PM.png" width="811" height="186"><figcaption>LOVE sentiment and message volume as of April 10 | Source: Stocktwits</figcaption></figure>One user expressed concerns over the additional stores the company has opened recently and the high inventory.<stembedurl>https://stocktwits.com/DT3755/message/611200694</stembedurl>Another user said investors were buying LOVE stock due to the fear of missing out.<stembedurl>https://stocktwits.com/BoomFlick/message/611226735</stembedurl><a href="https://stocktwits.com/symbol/LOVE">Shares of LOVE</a> are down nearly 22% year to date.For updates and corrections, email newsroom[at]stocktwits[dot]com.

Liliya Kalkamanova relaxes in Lovesac's Cloud-Like Comfort during NYFW: The Shows 2022 on February 15, 2022 in New York City. (Photo by Bryan Bedder/Getty Images for IMG Fashion)

Lovesac Pops On Strong Q4 Results: Retail Investors Turn Extremely Bullish

Lovesac is known for its giant beanbags called "Sacs", which are filled with a proprietary Durafoam blend instead of beans or beads.

Equity

Daktronics Inc. (DAKT) tumbled as much as 27%&nbsp;at the opening bell on Wednesday, marking its sharpest intraday decline in more than two years, after the video display supplier reported third-quarter results that fell short of Wall Street expectations.The company also announced that Reece Kurtenbach will step down from his roles as&nbsp;President, Chief Executive, and Chairman of the Board, effective March 5. Daktronics has hired an executive search firm to assist in finding a permanent replacement.&nbsp;In the interim, the board has appointed Brad Wiemann, the company’s Executive Vice President, as President and CEO. Wiemann, who has been with Daktronics since 1993, will take over leadership immediately.The company posted a loss of $0.36 per share, missing analyst forecasts of a $0.06 earnings per share (EPS).&nbsp;Revenue came in at $36 million – far below the $175 million Wall Street had anticipated, according to Stocktwits data.Its net loss for the quarter was $17.2 million as product orders decreased 2.7% to $186.9 million compared to the previous quarter.In its earnings statement, Daktronics cited broader economic pressures, including global tariff policies and shifting federal funding priorities, as factors impacting near-term business conditions.&nbsp;The company noted delays in U.S.-based project bookings and warned that&nbsp;corporate governance and business transformation costs would remain elevated in the fourth fiscal quarter.Despite these challenges, Daktronics reaffirmed its long-term outlook. The company expects to grow revenue&nbsp;faster than its addressable market – currently estimated at 7% to 10%&nbsp; – while expanding operating margins to a sustainable 10% to 12% and achieving a 17% to 20% return on capital by fiscal 2028.<figure class="image"><img style="aspect-ratio:1296/296;" src="https://st-everywhere-cms-prod.s3.us-east-1.amazonaws.com/Screenshot_2025_03_05_093823_240fd6ce29.png" alt="Screenshot 2025-03-05 093823.png" width="1296" height="296"><figcaption>Daktronics retail sentiment and message volume on March 5 as of 9:40 a.m. ET | Source: Stocktwits</figcaption></figure>Despite the sharp dip, retail sentiment on Stocktwits around&nbsp;<a href="https://stocktwits.com/symbol/DAKT">Daktronics’ stock</a> flipped to ‘bullish’ from ‘bearish’ a day earlier.&nbsp;The stock, which has already fallen more than 37% this year, slid below its 200-day simple moving average (SMA) following Wednesday’s decline.&nbsp;For updates and corrections, email newsroom[at]stocktwits[dot]com.Read also:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/barrick-gold-stock-ubs-upgrade-mali-deal-catalyst/cheZvYZR6O">Barrick Gold Stock Draws Attention After UBS Upgrade Highlights Mali Deal As Catalyst – Retail Remains Skeptical</a>

Daktronics worker does some electrical work to the time clock above the goal in Reliant Stadium in Houston, Texas. (Photo by Nick de la Torre/Houston Chronicle via Getty Images)

Daktronics Stock Sees Biggest Drop In Over 2 Years As Q3 Earnings Disappoint, CEO Exits – Retail Sentiment Flips

The company highlighted delays in U.S.-based project bookings and warned that corporate governance and business transformation costs would remain elevated in the fourth fiscal quarter.

Shares of Emergent BioSolutions plunged more than 8% in after-hours trading on Monday after the company reported a steep revenue drop in the fourth quarter.&nbsp;While Emergent swung to a profit, the earnings beat failed to offset concerns over its shrinking top line.The medical contract development and manufacturing firm posted adjusted net income of $0.05 per diluted share, a sharp reversal from the $0.77 per share loss a year earlier. Analysts had expected a loss of $0.43 per share.&nbsp;However, quarterly revenue fell to $194.7 million from $276.6 million a year ago, well below the consensus estimate of $249.5 million.For the first quarter, Emergent forecasted revenue in the range of $200 million to $240 million, lower than an analyst estimate of $279 million.&nbsp;For 2025, the company projected revenue of $750 million to $850 million, significantly trailing the $1.11 billion analysts had expected.“We delivered favorable full-year financial results driven by our core products, all the while completing a series of strategic stabilization actions to strengthen our financial position ahead of plan,” CEO Joe Papa said.&nbsp;“This strong foundation enables Emergent to focus on profitable revenue growth and cash generation as we move forward with turnaround activities, a critical phase in our multi-year transformation plan.”Despite the revenue shortfall, retail traders on Stocktwits remained optimistic, with sentiment for EBS ending Monday in the ‘bullish’ zone.&nbsp;Many users focused on the company’s improving profitability rather than its shrinking revenue.&nbsp;One trader compared the current situation to a period before Emergent had its Narcan opioid overdose nasal spray in its portfolio, arguing that profitability was the key factor.<stembedurl>https://stocktwits.com/WinstonSmith33/message/606629996</stembedurl>Another user pointed to CEO Joe Papa’s comments on the earnings call, noting that the company’s 2025 guidance appeared “conservative.”&nbsp;<stembedurl>https://stocktwits.com/GrantDiaz/message/606587312</stembedurl>Some traders speculated that Emergent’s mpox vaccine sales had not yet been factored into the guidance.&nbsp;While the company’s smallpox vaccine has been used for mpox, it has not yet&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/govx-siga-ebs-cmrx-stocks-gain-who-declares-who-public-health-emergency/cJId4JgRge">received</a> formal FDA approval for that indication.<a href="https://stocktwits.com/symbol/EBS">Emergent BioSolutions shares</a> are down more than 28% year-to-date but have more than doubled over the past 12 months.For updates and corrections, email newsroom[at]stocktwits[dot]com.

Stock market down on a black background. | Image source: Yuichiro Chino via Getty Images

Emergent BioSolutions Stock Sinks As Q4 Revenue Plunges 30%, But Retail Clings To Profit Swing

For the first quarter, Emergent forecasted revenue in the range of $200 million to $240 million, lower than an analyst estimate of $279 million.

Emergent BioSolutions Stock Sinks As Q4 Revenue Plunges 40%, But Retail Clings To Profit Swing

For the first quarter, Emergent forecasted revenue in the range of $200 million to $240 million, lower than an analyst estimate of $279 million.


AVUV
American Century ETF Trust - Avantis U.S. Small Cap Value ETF

Feed

News

Sentiment

Fundamentals

Info

Latest AVUV News

AVUV American Century ETF Trust - Avantis U.S. Small Cap Value ETF